Latisse (Bimatoprost SOLUTION/DROPS) 0.3 mg/mL

Bimatoprost, the active ingredient in Latisse, is a prostaglandin F2α analog. It prolongs the anagen (growth) phase of the hair follicle, which increases the number of eyelash hairs that grow and the duration of their growth, resulting in longer, thicker, and darker lashes.

The usual dose of Latisse is one application nightly to the skin of the upper eyelid margin at the base of the eyelashes. The prescriber will determine the appropriate dosage based on individual patient needs.

Latisse is classified as a pregnancy category C drug, meaning that it should be used during pregnancy only if the potential benefits justify the potential risks. It is not known whether bimatoprost is excreted in human milk, so caution should be exercised when using Latisse while breastfeeding.

To order Latisse from GNH India, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams across international markets and will ask the buyer to confirm trade or institutional credentials. The team will then reply with pricing, availability, shipping, and the import paperwork.

Latisse is a prescription treatment that has been clinically proven to increase the length, thickness, and darkness of eyelashes. Compared to other eyelash growth treatments, Latisse is a prostaglandin analog, which is a specific class of medication that targets the hair growth cycle. Other treatments may use different mechanisms or ingredients, and their effectiveness can vary.

Latisse should be stored at 36°F to 77°F (2°C to 25°C). Keep it in the original packaging, protect it from light, and do not freeze. Ensure the face is clean, makeup and contact lenses are removed before application, and use a new sterile applicator for each eye to minimize contamination.

Latisse is applied nightly to the skin of the upper eyelid margin at the base of the eyelashes using the accompanying sterile applicators. One drop of the solution is placed on the applicator, which is then drawn carefully across the upper eyelid margin. Any excess solution should be blotted with a tissue or other absorbent material.

The most serious risks associated with Latisse include increased brown pigmentation of the colored part of the eye, which is likely to be permanent, and hair growth in other areas of the skin that frequently touch the solution. It is important to follow the application instructions carefully to minimize these risks.

Latisse should not be used by individuals with a known hypersensitivity to bimatoprost. It should also be used with caution in patients with a history of abnormal intraocular pressure (IOP) or those using other products in the same class for elevated IOP, as it should only be used under the close supervision of a physician in such cases.